SNP Detail For rs11115148
1.Mapping Information
Human SNP ID rs11115148
Human chromosome chr12
Human SNP position 81995345
Pig chromosome chr5
Pig SNP position 104391762
2.Annotation Information
PubMed ID21844884
JournalPharmacogenomics J
Linkwww.ncbi.nlm.nih.gov/pubmed/21844884
StudyGenome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations
Disease/TraitResponse to platinum-based chemotherapy (cisplatin)
Initial sample176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines
Replication sampleNA
Region12q21.31
Chromosome idchr12
Chromosome position81995345
Reported geneintergenic
Mapped geneLOC101928449 - LOC105369873
Upstream gene id101928449
Downstream gene id105369873
SNP gene ids
Upstream gene distance2212
Downstream gene distance143000
SNP risk allelers11115148-?
SNPsrs11115148
Merged0
SNP id current11115148
Contextupstream_gene_variant
Intergenic1
Allele frequency
P value0.000002
Pvalue mlog5.69897000433601
P value text
Or beta
%95 Ci
PlatformNR [~ 3000000] (imputed)
CNVN
Mapped traitresponse to cisplatin
Mapped trait URIhttp://purl.obolibrary.org/obo/GO_0072718
Study accessionGCST001201